Yamaguchi Hideki, Miyazaki Makoto
Department of Cancer Cell Research, Sasaki Institute, Sasaki Foundation, Tokyo, Japan.
Cancer Sci. 2025 May;116(5):1171-1180. doi: 10.1111/cas.70021. Epub 2025 Feb 13.
Peritoneal metastasis, also known as peritoneal dissemination or carcinomatosis, refers to the spread of cancer to the peritoneum that lines the abdominal and pelvic cavities and covers the abdominal organs. Peritoneal metastasis typically occurs in advanced cancers of abdominal origin, most commonly gastrointestinal and gynecological cancers. Conventional chemotherapy has limited efficacy, and no effective molecular-targeted therapy is currently available for peritoneal metastasis. As a result, peritoneal metastasis is associated with poor outcomes and significantly reduced quality of life in patients with advanced cancers. This is largely due to a limited understanding of the molecular and cellular mechanisms underlying peritoneal metastasis. However, recent studies employing innovative approaches have provided novel insights into the mechanisms of peritoneal metastasis, contributing to the development of novel therapeutic strategies. In this review, we summarize recent findings on the cell biological aspects of peritoneal metastasis and potential therapeutic target molecules. In particular, we emphasize the importance of cancer cell clustering within the abdominal cavity, which drives multiclonal peritoneal seeding. We also focus on the interactions of cancer cells with mesothelial cells and cancer-associated fibroblasts within the peritoneal tumor microenvironment.
腹膜转移,也称为腹膜播散或癌性腹膜炎,是指癌症扩散至覆盖腹腔和盆腔并包裹腹部器官的腹膜。腹膜转移通常发生于起源于腹部的晚期癌症,最常见的是胃肠道和妇科癌症。传统化疗疗效有限,目前尚无针对腹膜转移的有效分子靶向治疗方法。因此,腹膜转移与晚期癌症患者的不良预后及生活质量显著下降相关。这在很大程度上是由于对腹膜转移潜在的分子和细胞机制了解有限。然而,最近采用创新方法进行的研究为腹膜转移机制提供了新的见解,有助于开发新的治疗策略。在本综述中,我们总结了腹膜转移细胞生物学方面的最新发现以及潜在的治疗靶点分子。特别强调了癌细胞在腹腔内聚集的重要性,这推动了多克隆腹膜种植。我们还关注癌细胞与腹膜肿瘤微环境中的间皮细胞和癌症相关成纤维细胞之间的相互作用。